BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21982687)

  • 1. In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure.
    Aronow WS; Rich MW; Goodlin SJ; Birkner T; Zhang Y; Feller MA; Aban IB; Jones LG; Bearden DM; Allman RM; Ahmed A
    J Am Med Dir Assoc; 2012 Jun; 13(5):448-52. PubMed ID: 21982687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure.
    Arundel C; Sheriff HM; Lam PH; Mohammed SF; Jones LG; Jurgens CY; Morgan CJ; Faselis C; Allman RM; Fonarow GC; Ahmed A
    Am J Ther; 2020; 27(3):e235-e242. PubMed ID: 30299270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blockers for heart failure.
    Heran BS; Musini VM; Bassett K; Taylor RS; Wright JM
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003040. PubMed ID: 22513909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.
    Zhang Y; Fonarow GC; Sanders PW; Farahmand F; Allman RM; Aban IB; Love TE; Levesque R; Kilgore ML; Ahmed A
    Am J Cardiol; 2011 Nov; 108(10):1443-8. PubMed ID: 21890091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of care of nursing home residents hospitalized with heart failure.
    Ahmed A; Weaver MT; Allman RM; DeLong JF; Aronow WS
    J Am Geriatr Soc; 2002 Nov; 50(11):1831-6. PubMed ID: 12410902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
    Chen JY; Kang N; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
    J Healthc Qual; 2011; 33(4):29-36. PubMed ID: 21733022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study.
    Cespón-Fernández M; Raposeiras-Roubín S; Abu-Assi E; Manzano-Fernández S; Flores-Blanco P; Barreiro-Pardal C; Castiñeira-Busto M; Muñoz-Pousa I; López-Rodríguez E; Caneiro-Queija B; Cobas-Paz R; Fernández-Barbeira S; Domínguez-Erquicia P; Domínguez-Rodríguez LM; López-Cuenca Á; Gómez-Molina M; Baz-Alonso JA; Calvo-Iglesias F; Valdés-Chávarri M; Íñiguez-Romo A
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):487-495. PubMed ID: 30924021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of acutely decompensated systolic heart failure over the 2003-2013 decade in Douala General Hospital, Cameroon.
    Lemogoum D; Kamdem F; Ba H; Ngatchou W; Hye Ndindjock G; Dzudie A; Monkam Y; Mouliom S; Hermans MP; Bika Lele EC; van de Borne P
    ESC Heart Fail; 2021 Feb; 8(1):481-488. PubMed ID: 33225620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure.
    Forman DE; Chander RB; Lapane KL; Shah P; Stoukides J
    J Am Geriatr Soc; 1998 Dec; 46(12):1550-4. PubMed ID: 9848817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
    PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
    Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV
    Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
    PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey on the management of heart failure in individuals over 80 years of age in French geriatric care units.
    Boully C; Vidal JS; Guibert E; Ghazali FN; Pesce A; Beauplet B; Roger JD; Carrière I; Timbely B; Idiri H; Constensoux JP; Durocher AM; Dubail D; Fargier M; Jeandel C; Berrut G; Hanon O;
    BMC Geriatr; 2019 Aug; 19(1):204. PubMed ID: 31370798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.